AbCellera Biologics (ABCL) Research & Development: 2019-2024
Historic Research & Development for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $167.3 million.
- AbCellera Biologics' Research & Development rose 72.14% to $48.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $175.7 million, marking a year-over-year increase of 62.83%. This contributed to the annual value of $167.3 million for FY2024, which is 4.78% down from last year.
- As of FY2024, AbCellera Biologics' Research & Development stood at $167.3 million, which was down 4.78% from $175.7 million recorded in FY2023.
- AbCellera Biologics' 5-year Research & Development high stood at $175.7 million for FY2023, and its period low was $29.4 million during FY2020.
- For the 3-year period, AbCellera Biologics' Research & Development averaged around $150.3 million, with its median value being $167.3 million (2024).
- Its Research & Development has fluctuated over the past 5 years, first spiked by 190.65% in 2020, then dropped by 4.78% in 2024.
- Over the past 5 years, AbCellera Biologics' Research & Development (Yearly) stood at $29.4 million in 2020, then spiked by 111.15% to $62.1 million in 2021, then skyrocketed by 73.82% to $107.9 million in 2022, then soared by 62.83% to $175.7 million in 2023, then declined by 4.78% to $167.3 million in 2024.